News
Hosted on MSN27d
Capgemini and Dai-ichi Life sign multi-year agreement to establish Global Capability Centre in India - MSNCapgemini and Dai-ichi Life sign multi-year agreement to establish Global Capability Centre in India The collaboration will leverage a broad spectrum of the GCC’s digital capabilities (Photo | ANI) ...
Capgemini and Dai-ichi Life Holdings have signed a multi-year agreement to set up a global capability centre (GCC) in India to tap local talent and support the IT and digital strategies of the ...
Researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a broad-spectrum drug that can target a range of coronaviruses using physics-driven modeling — a ...
More information: Charles B. Reilly et al, Broad-spectrum coronavirus inhibitors discovered by modeling viral fusion dynamics, Frontiers in Molecular Biosciences (2025). DOI: 10.3389/fmolb.2025. ...
Dai-ichi Life Group, a leading insurance company from Japan, is teaming up with global tech company Capgemini to open a new technology center in Hyderabad, India. This center will play a big role ...
AgroSpheres and Wilbur-Ellis launch FUN-THYME™ , a powerful broad-spectrum biofungicide built on novel AgriCell® technology.
AgroSpheres, a biotechnology company transforming crop protection with biobased innovations, today announced the commercial launch of FUN-THYME™, a groundbreaking, broad-spectrum biofungicide ...
Nippon Ichi Software Inc. (3851.TO) Japan Year Ended March 31 GROUP 2025 2024 Revenue Y5.30 bln Y5.34 bln Operating Profit (Y274.00 mln) Y401.00 mln Pretax Profit (Y75.00 mln) Y842.00 mln Net ...
Painting one’s home is no longer just about freshening up walls. In today’s world—where a vibrant cultural legacy intersects ...
Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results